Discover how print and digital clinical study materials, developed with clarity, white space, and purpose, improve participant understanding and engagement. White space refers to the empty area around print and design text and graphic elements. Long ago, in a different industry, I was part of…
-
Ancillary Clinical Trial Supplies and EquipmentClinical Trial Business InsightsParticipant Engagement
Wearables & AI in Clinical Trials: Balancing Innovation & Integrity
by Ted Corriganby Ted CorriganAI-driven analysis enabled by wearable devices has become an influential tool shaping modern clinical research. The technology embedded in today’s clinical trial wearables has evolved into a meaningful scientific and operational capability that can influence how studies are designed, conducted, and interpreted. While the use of…
-
Ancillary Clinical Trial Supplies and EquipmentClinical Trial Business InsightsClinical Trial Life-Science Events
From Operations to Strategy: What SCOPE 2026 Revealed About the Future of Clinical Supply and RTSM
by Dan McDonaldby Dan McDonaldThe center of gravity in clinical trials is shifting. Conversations that once lived in separate silos, such as vendor onboarding, randomization, and trial supply management (RTSM), are now deeply interconnected. That reality was on full display while chairing the IRT/RTSM: Navigating the Digital Neighborhood component of…
-
Ancillary Clinical Trial Supplies and EquipmentClinical Trial Business Insights
Strategies for Risk Mitigation to Prevent Deviations in Clinical Trials
Every clinical trial relies on precision, and effective risk mitigation for clinical trial deviations is crucial at every step. Timelines are tight, data must be reliable, and patient safety is non‑negotiable. In this environment, even a small error can trigger a deviation that can significantly…
-
Ancillary Clinical Trial Supplies and EquipmentClinical Trial Business Insights
Impact of Tariffs on Clinical Trials: Navigating Today’s New Reality
by Dan McDonaldby Dan McDonaldTariffs have always been part of clinical trials. Whenever supplies, equipment, or study materials cross borders, duties and fees are part of the process. For years, these costs were predictable enough to be absorbed into budgets and timelines. Sponsors and CROs planned accordingly, and study…